|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Realized investment gains (loss), net | |||||
| Unrealized investment gain, net | |||||
| Stock-based compensation | |||||
| Bad debt expense | |||||
| Gain on foreign currency translation | |||||
| Changes in operating assets and liabilities: | |||||
| Trade accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets and liabilities | |||||
| Accounts payable and accrued liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Investing Activities: | |||||
| Purchases of debt securities | |||||
| Proceeds from sales of debt securities | |||||
| Purchase of property and equipment | |||||
| Net cash provided by (used in) investing activities | |||||
| Common stock issuance | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Interest | |||||
| Income taxes | |||||
Loading...